Monte Rosa Therapeutics, Inc. GLUE
11.77
0.05
0.43%
as of 25 Sep
- Market cap
- $999.9M
- P/E
- 0.0×
Follow GLUE
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '17 | |
|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | — | — | — | — | — | — |
P/S ratio |
10.53 | 6.78 | — | — | — | — | — | — |
P/FCF ratio |
0.00 | 13.50 | — | — | — | — | — | — |
P/Operating CF |
(30.28) | 3.98 | — | — | — | — | — | — |
P/B ratio |
5.59 | 2.30 | — | — | — | — | — | — |
Price to Tangible BV |
5.59 | 2.30 | — | — | — | — | — | — |
EV/Sales |
7.48 | 1.86 | — | — | — | — | — | — |
EV/EBITDA |
0.00 | 0.00 | — | — | — | — | — | — |
EV/Operating CF |
(40.59) | 3.35 | — | — | — | — | — | — |
EV/FCF |
(33.66) | 3.70 | — | — | — | — | — | — |
Quick Ratio |
6.05 | 2.37 | 5.00 | 10.62 | 20.80 | 1.42 | 2.15 | — |
Current Ratio |
6.12 | 2.40 | 5.07 | 10.79 | 20.96 | 1.49 | 2.27 | — |
Net Debt/EBITDA |
8.22 | 5.10 | 1.70 | 2.43 | 4.89 | 1.52 | (1.23) | — |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 170.81% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | (1.56) | — |
Asset Turnover |
0.28 | 0.20 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Operating CF/Net income |
0.59 | (0.58) | 0.32 | 0.85 | 0.80 | 0.64 | 0.80 | — |
Capex/Depreciation |
(0.56) | (0.49) | (3.05) | (3.42) | (4.53) | (6.31) | 0.00 | — |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
| (16.94%) | (36.15%) | (60.07%) | (35.06%) | (49.51%) | 117.88% | 25.43% | — | |
| (8.71%) | (19.58%) | (41.90%) | (30.62%) | (35.58%) | (118.66%) | (139.53%) | — | |
ROIC |
0.00% | 0.00% | 0.00% | (920.94%) | (3,154.52%) | 0.00% | 0.00% | — |
Return on Tangible Assets |
(10.88%) | (29.08%) | (60.58%) | (39.11%) | (21.48%) | (189.45%) | (113.79%) | — |
Average Days of Receivables |
34.24 | 0.84 | 0.00 | 0.00 | — | — | — | — |
Research and Development Expense of Revenue |
114.42% | 160.75% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — |
Selling, General and Administrative Expense of Revenue |
29.42% | 46.51% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
15.25% | 23.97% | 0.00% | 0.00% | 0.00% | 0.00% | — | — |
Graham Net Nets |
0.14 | 0.32 | — | — | — | — | — | — |
Graham Number |
0.00 | 0.00 | — | — | — | — | — | — |
Earnings Yield |
(2.93%) | (14.70%) | — | — | — | — | — | — |
Free Cash Flow Yield |
(2.11%) | 7.41% | — | — | — | — | — | — |
Revenue per Share |
1.49 | 1.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Operating CF per Share |
(0.27) | 0.57 | (0.85) | (1.96) | (2.37) | (15.20) | (0.14) | — |
Capex per Share |
(0.06) | (0.05) | (0.37) | (0.27) | (0.39) | (2.23) | 0.00 | — |
Free Cash Flow per Share |
(0.33) | 0.51 | (1.22) | (2.23) | (2.76) | (17.43) | (0.14) | — |
Cash per Share |
4.54 | 5.04 | 4.52 | 5.59 | 13.84 | 27.49 | 0.21 | — |
Shareholders Equity per Share |
2.81 | 3.02 | 3.49 | 5.75 | 13.90 | (32.12) | (0.28) | — |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Book value per Share |
2.81 | 3.02 | 3.49 | 5.75 | 13.90 | (32.12) | (0.28) | — |
Free Cash Flow |
(27.50) | 38.01 | (62.78) | (105.27) | (69.02) | (26.44) | (6.17) | — |
Working Capital |
328.97 | 220.49 | 189.62 | 250.32 | 332.03 | 14.32 | 5.47 | — |
Capital Expenditures |
(4.70) | (3.99) | (18.98) | (12.80) | (9.65) | (3.39) | (1.38) | — |
Net Current Asset Value |
177.58 | 161.64 | 111.71 | 204.91 | 329.85 | (54.51) | (13.48) | — |
EV/EBIT |
0.00 | 0.00 | — | — | — | — | — | — |
Capex to Sales |
0.04 | 0.05 | 0.00 | 0.00 | 0.00 | 0.00 | — | — |
Net Profit Margin |
(31.23%) | (96.14%) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — |
Price to Operating Income |
0.00 | 0.00 | — | — | — | — | — | — |
| Other line items | ||||||||
Depreciation/Fixed assets |
0.32 | 0.28 | 0.18 | 0.14 | 0.17 | 0.12 | 0.05 | — |
Cash ROIC |
(8.00%) | 2.10% | (18.85%) | (22.34%) | (10.34%) | 393.74% | (46.79%) | — |
Accounts Receivable Turnover |
21.01 | 223.07 | 0.00 | — | — | — | — | — |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | — |
Inventory Turnover |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | — |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 16,196.88 | — |
Days of Inventory on Hand |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | — |
Average Receivables |
5.89 | 0.34 | 4.08 | — | — | — | — | — |
Average Payables |
10.38 | 14.18 | 9.51 | 7.21 | 6.81 | 5.13 | 5.13 | — |
Average Assets |
443.70 | 371.24 | 323.07 | 354.36 | 207.85 | 30.24 | 5.55 | — |
Average Common Equity |
228.00 | 201.09 | 225.33 | 309.46 | 149.39 | (30.44) | (30.44) | — |
Columns are period end dates